Cala Trio™; The first non-invasive personalized therapy for hand tremors

Translate to Spanish or other 102 languages!

Source information: https://calatrio.com 

Mega Doctor News

- Advertisement -

The first targeted, wearable therapy designed to treat essential tremor (ET). The therapy delivers meaningful results for most patients after just a single session. Cala Trio™ requires a prescription from a medical doctor.

Source information: https://calatrio.com 

The Science

Surface stimulation delivered at your wrist is thought to disrupt the central tremor network in your brain that causes the hand tremor.

- Advertisement -
  • Developed through Clinical Studies
  • 64% of patients reported having persistent relief for an average of 94 minutes
  • 54% of patient’s tremor power improved by at least 50%

See if it’s right for you

A new approach to managing essential tremor

Non-invasive

Source information: https://calatrio.com 

Cala Trio™ is a wrist worn wearable therapy. No surgery or invasive procedures needed.

Drug Free

Source information: https://calatrio.com 

Tremor reduction without systemic side effects and drug interactions. A new individualized solution for essential tremor that fits with the flow of your life.

Easy to Try

Source information: https://calatrio.com 

There is no perfect treatment for everyone. If Cala Trio™ is not right for you, simply return within 60 days for a full refund less the $99 trial fee.

- Advertisement -

Results

The image below is an actual patient test (Archimedes Spiral Task) before and after a 40-minute stimulation therapy with Cala Trio.

Indications for Use

Cala Trio is indicated to aid in the transient relief of hand tremors in the treated hand following stimulation in adults with essential tremor. Please refer to the Safety Information for a complete listing of warnings and cautions.

Caution: Federal law restricts this device to sale by or on the order of a physician.

Visit https://calatrio.com for more information. All information is sourced from this site. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

AACT NOW to Launch Rally the Vote Across Rio Grande Valley

The Advocacy Alliance Center of Texas, known as AACT NOW, will officially launch its Rally the Vote initiative Thursday, Oct. 1, bringing together community partners working to expand access to accurate, nonpartisan election information across the Rio Grande Valley.

STHS and Prominence Health Empower Seniors This World Heart Day

World Heart Day serves as a powerful reminder that cardiovascular disease remains one of the greatest threats to the health and well-being of older adults.

DHR Health Offers Mammogram Screening Special During “Breast Cancer Awareness Month”

October is “Breast Cancer Awareness Month,” and DHR Health is encouraging women to prioritize their breast health by offering their annual mammogram screening special.

FDA Approves First Treatment for MCT8 Deficiency

The U.S. Food and Drug Administration approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as rapid heart rate, increased blood pressure and adverse effects on metabolism) in patients with MCT8 deficiency, also known as Allan-Herndon-Dudley syndrome.
- Advertisement -